Aletta Kraneveld new Vice-Dean of Research at Faculty of Science
Prof. Aletta Kraneveld has been named the new Vice-Dean of Research at the Faculty of Science. She will begin work in her new position on 1 March 2020, following in the footsteps of Sjef Smeekens, who will resign from the administrative position after serving two terms. Kraneveld has been Professor of Interdisciplinary Translational Pharmacology at the Faculty of Science since 2016. She was appointed by the Faculty Board in collaboration with the Executive Board.
Dean Isabel Arends is excited about the prospect of working with Kraneveld: 鈥淧rof. Aletta Kraneveld is an excellent immuno-pharmacologist with considerable experience in Life Sciences research, one of the most important strategic themes at the faculty and the university. Through her work in the hubs Future Food Utrecht and Utrecht Exposome, she also cooperates with many industrial and social partners. And as a member of the Integrity Committee, she has had an opportunity to become acquainted with the rest of Utrecht 木瓜福利影视 as well.鈥
Farewell to Sjef Smeekens
Kraneveld will take over the baton from Sjef Smeekens, who has served two three-year terms as Vice-Dean of Research. After the departure of Gerrit van Meer in 2018, he also served a half-year as the adjunct Dean of the Faculty of Science. 鈥淲e鈥檒l miss him鈥, says Arends. 鈥淏ut we also realise that he鈥檚 looking forward to devoting more time to his research in plant physiology, a field that鈥檚 experiencing some major developments.鈥
About Aletta Kraneveld
Professor Kraneveld studied Pharmaceutical Sciences at the 木瓜福利影视 of Amsterdam and Utrecht 木瓜福利影视. She earned her PhD at Utrecht 木瓜福利影视 in 1994, then went on to perform research at institutions such as Glaxo in England and Harvard Medical School in Boston. Upon her return to Utrecht, she specialised in immuno-pharmacology, and was appointed full professor in 2016. In 2018, it was announced that Kraneveld would be participating in a major international study into the role the intestines play in autism. The European Commission set aside 14 million euros for this project.